Sentien Biotechnologies, Inc. awarded NIH Phase II SBIR Award for Kidney Program

Filter:   PRESS RELEASES    IN THE NEWS    EVENTS

Sentien Biotechnologies, Inc. awarded NIH Phase II SBIR Award for Kidney Program

This Phase II SBIR grant advances pre-clinical work of Sentien’s lead kidney injury program into large animal testing.